美国 · SEC FORM 4
Pasithea Therapeutics Corp.
KTTA · Nasdaq · CIK 0001841330 · Healthcare · Biotechnology
内部人信号
1 位买方 · 1 条买入交易行 · $53.0K 买入总额
为什么有这个信号？
评分构成
每条进度条表示其对当前分数的贡献；权重和公式保持不变。
哪些因素限制了当前分数？
- ⚠ Cluster breadth is moderate · 1 insider(s), not 4+
- ⚠ Purchase size is modest relative to the model scale
- ⚠ 角色得分低 · 买入者中职位最高的是：TenPercentOwner（CEO、董事长和持股 10% 以上的股东得分最低）
- ⚠ Purchase activity is becoming less recent
Purchase-size comments are relative to the model scale. Average daily volume is a separate market-context diagnostic.
US-v1.2 按当前 180 天规则给合资格的股票买入打分。分数只表示研究的先后，不是收益预测或概率。回测没有显示美国分数越高、之后的表现越好。
买方广度与集中度
Roles in the peak window: TenPercentOwner. Concentration uses priced qualifying P lines only and does not change the saved score.
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
—
信号历史
最新留档分数
- 37.9
- 37.8
- 37.8
- 37.8
- 37.8
Only scores saved when a full US scoring run completed are shown; gaps are not reconstructed.
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
市场背景补充近期价格表现与风险信息，不影响内部人信号。
价格表现
- 1M
- -13.3%
- 3M
- -4.5%
- 6M
- -33.1%
- 12M
- -42.9%
波动率与流动性
- 波动率
- 131.6%
- Beta
- —
- 平均每日成交额
- USD 103,373
估值
- 市值
- USD 15.6M
- P/E
- —
基本面
- 利润率
- —
- ROE
- -37.0%
- 细分行业
- Biotechnology
市场数据
价格数据截至：2026-10-11 · 价格来源：OpenBB/yfinance; 成交量来自 本机价格缓存 (yfinance) · 来自 SEC 申报文件：市值, ROE · 财年截止日：2025-12-31 · 市值 = 申报文件封面所列的已发行股数 × 最新收盘价。股数日期：2026-08-12 · Status: PASS
空头余额
空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。
- 空头股数
- 159,831
- 上期报告
- 270,085
- 日均成交量
- 151,144
- 回补天数
- 1.1
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-06-17 | Coastlands Capital LP | 买入 (P) | Common Stock | 100,000 | USD 0.53 | USD 53,000 | SEC 申报 ↗ |
| 2025-11-28 | STEINMAN LAWRENCE | 买入 (P) | Common Stock | 133,333 | USD 0.75 | USD 100,000 | SEC 申报 ↗ |
| 2025-11-28 | Marques Tiago | 买入 (P) | Common Stock | 33,333 | USD 0.75 | USD 25,000 | SEC 申报 ↗ |
| 2025-11-28 | Dumesnil Simon | 买入 (P) | Common Stock | 33,333 | USD 0.75 | USD 25,000 | SEC 申报 ↗ |
| 2023-06-02 | STEINMAN LAWRENCE | 买入 (P) | Common Stock | 30,000 | USD 0.43 | USD 12,900 | SEC 申报 ↗ |
| 2022-10-17 | Concord IP2 Ltd.; Delaney David; Elderhill Corp | 买入 (P) | Common Stock | 1,000 | USD 1.11 | USD 1,110 | SEC 申报 ↗ |
| 2022-09-29 | Camac Capital, LLC; Camac Fund, LP; Camac Partners, LLC; Shahinian Eric | 买入 (P) | Common Stock | 6,710 | USD 1.16 | USD 7,784 | SEC 申报 ↗ |
| 2022-09-28 | Camac Capital, LLC; Camac Fund, LP; Camac Partners, LLC; Shahinian Eric | 买入 (P) | Common Stock | 57,647 | USD 1.19 | USD 68,600 | SEC 申报 ↗ |
| 2022-09-06 | Camac Capital, LLC; Camac Fund, LP; Camac Partners, LLC; Shahinian Eric | 买入 (P) | Common Stock | 21,748 | USD 1.13 | USD 24,575 | SEC 申报 ↗ |
| 2022-09-02 | Camac Capital, LLC; Camac Fund, LP; Camac Partners, LLC; Shahinian Eric | 买入 (P) | Common Stock | 11,507 | USD 1.14 | USD 13,118 | SEC 申报 ↗ |
| 2022-09-01 | Camac Capital, LLC; Camac Fund, LP; Camac Partners, LLC; Shahinian Eric | 买入 (P) | Common Stock | 55,646 | USD 1.13 | USD 62,880 | SEC 申报 ↗ |
| 2022-08-30 | Camac Capital, LLC; Camac Fund, LP; Camac Partners, LLC; Shahinian Eric | 买入 (P) | Common Stock | 17,828 | USD 1.15 | USD 20,502 | SEC 申报 ↗ |
| 2022-08-29 | Camac Capital, LLC; Camac Fund, LP; Camac Partners, LLC; Shahinian Eric | 买入 (P) | Common Stock | 5,000 | USD 1.17 | USD 5,850 | SEC 申报 ↗ |
| 2022-08-19 | Geller Avi; Leonite Capital LLC; Leonite Fund I, LP | 买入 (P) | Common Stock | 54,644 | USD 1.30 | USD 71,037 | SEC 申报 ↗ |
| 2022-08-17 | Camac Capital, LLC; Camac Fund, LP; Camac Partners, LLC; Shahinian Eric | 买入 (P) | Common Stock | 155,773 | USD 1.21 | USD 188,485 | SEC 申报 ↗ |
Form 4 申报证据
6 transaction lines in the latest 365-day window; 43 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-06-17 | Coastlands Capital LP | 买入 (P) | Common Stock | 100,000 | USD 0.53 | USD 53,000 | SEC 申报 ↗ |
| 2025-11-28 | Schneiderman Daniel H | 奖励／授予 (A) | Common Stock | 26,667 | USD 0.75 | USD 20,000 | SEC 申报 ↗ |
| 2025-11-28 | STEINMAN LAWRENCE | 买入 (P) | Common Stock | 133,333 | USD 0.75 | USD 100,000 | SEC 申报 ↗ |
展开近期 Form 4 证据 (6 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-06-17 | Coastlands Capital LP | 买入 (P) | Common Stock | 100,000 | USD 0.53 | USD 53,000 | SEC 申报 ↗ |
| 2025-11-28 | Schneiderman Daniel H | 奖励／授予 (A) | Common Stock | 26,667 | USD 0.75 | USD 20,000 | SEC 申报 ↗ |
| 2025-11-28 | STEINMAN LAWRENCE | 买入 (P) | Common Stock | 133,333 | USD 0.75 | USD 100,000 | SEC 申报 ↗ |
| 2025-11-28 | Marques Tiago | 买入 (P) | Common Stock | 33,333 | USD 0.75 | USD 25,000 | SEC 申报 ↗ |
| 2025-11-28 | Leahy Emer | 奖励／授予 (A) | Common Stock | 33,333 | USD 0.75 | USD 25,000 | SEC 申报 ↗ |
| 2025-11-28 | Dumesnil Simon | 买入 (P) | Common Stock | 33,333 | USD 0.75 | USD 25,000 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-19 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | KTTA |
| CIK | 0001841330 |
| 行业 | Healthcare |
| 细分行业 | Biotechnology Yahoo Finance |
| SEC SIC | 2834 Pharmaceutical Preparations |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 43 transaction lines from 2021-12-20 to 2026-06-17 15 P purchase lines · 1 S sale lines · 27 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-19. Mapping status is an audit field and does not erase SEC filing evidence.